Literature DB >> 21056668

Investigation of cerebrocortical and cerebellar pathology in canine fucosidosis and comparison to aged brain.

Gauthami S Kondagari1, Jessica Yang, Rosanne M Taylor.   

Abstract

Fucosidosis is a fatal inherited neurodegenerative disease. The pathologic changes in brain which occur with progression from preclinical to late clinical disease were investigated in fucosidosis affected dogs. As aging also causes neurodegeneration and lysosomal dysfunction, pathologic markers of fucosidosis were compared to changes in the aging canine brain. Preclinical fucosidosis cerebral cortex and cerebellum revealed early increases in all neurodegenerative markers studied including apoptosis (2.1 fold), pyramidal neuronal loss (0.9 fold decrease) and Purkinje cell loss (1.2 fold decrease) compared to age matched controls. Increased axonal spheroid formation (>100 fold in cortex, 80 fold in cerebellum), microgliosis (9.2 fold) and astrocytosis (2.1 fold in cortex and 0.5 fold in cerebellum) were distinctive features of preclinical fucosidosis brain in all regions examined. This neuropathology progressed as the dogs developed severe clinical signs, with advanced fucosidosis brain exhibiting the greatest parenchymal destruction. These measures of the neurodegenerative and inflammatory changes in fucosidosis brain will assist monitoring disease progression and response to therapy. Crown
Copyright © 2010. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21056668     DOI: 10.1016/j.nbd.2010.10.026

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  8 in total

1.  Evaluation of Disease Lesions in the Developing Canine MPS IIIA Brain.

Authors:  Leanne K Winner; Neil R Marshall; Robert D Jolly; Paul J Trim; Stephen K Duplock; Marten F Snel; Kim M Hemsley
Journal:  JIMD Rep       Date:  2018-06-20

2.  Increased cerebellar volume in the early stage of fucosidosis: a case control study.

Authors:  Thomas Kau; Christoph Karlo; Tayfun Güngör; Viola Prietsch; Christian J Kellenberger; Ianina Scheer; Eugen Boltshauser
Journal:  Neuroradiology       Date:  2011-03-08       Impact factor: 2.804

3.  Ethanol withdrawal hastens the aging of cytochrome c oxidase.

Authors:  Marianna E Jung; Xiaohua Ju; Daniel B Metzger; James W Simpkins
Journal:  Neurobiol Aging       Date:  2011-03-24       Impact factor: 4.673

4.  Oligodendrocyte loss during the disease course in a canine model of the lysosomal storage disease fucosidosis.

Authors:  Jessica L Fletcher; Gauthami S Kondagari; Charles H Vite; Peter Williamson; Rosanne M Taylor
Journal:  J Neuropathol Exp Neurol       Date:  2014-06       Impact factor: 3.685

Review 5.  In Vivo NMR Studies of the Brain with Hereditary or Acquired Metabolic Disorders.

Authors:  Erica B Sherry; Phil Lee; In-Young Choi
Journal:  Neurochem Res       Date:  2015-11-26       Impact factor: 3.996

6.  A mouse model for fucosidosis recapitulates storage pathology and neurological features of the milder form of the human disease.

Authors:  Heike Wolf; Markus Damme; Stijn Stroobants; Rudi D'Hooge; Hans Christian Beck; Irm Hermans-Borgmeyer; Renate Lüllmann-Rauch; Thomas Dierks; Torben Lübke
Journal:  Dis Model Mech       Date:  2016-08-04       Impact factor: 5.758

7.  Sensorimotor and Neurocognitive Dysfunctions Parallel Early Telencephalic Neuropathology in Fucosidosis Mice.

Authors:  Stijn Stroobants; Heike Wolf; Zsuzsanna Callaerts-Vegh; Thomas Dierks; Torben Lübke; Rudi D'Hooge
Journal:  Front Behav Neurosci       Date:  2018-04-12       Impact factor: 3.558

8.  The effects of intracisternal enzyme replacement versus sham treatment on central neuropathology in preclinical canine fucosidosis.

Authors:  Gauthami Sudhamayee Kondagari; Jessica Louise Fletcher; Rachel Cruz; Peter Williamson; John J Hopwood; Rosanne Maree Taylor
Journal:  Orphanet J Rare Dis       Date:  2015-11-04       Impact factor: 4.123

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.